EGFR E746_A750del
|
NSCLC
|
EGFR E746_A750del
|
NSCLC
|
erlotinib Sensitive: C3 – Early Trials
|
erlotinib Sensitive: C3 – Early Trials
|
EGFR E746_A750del
|
NSCLC
|
EGFR E746_A750del
|
NSCLC
|
gefitinib Sensitive: C3 – Early Trials
|
gefitinib Sensitive: C3 – Early Trials
|
EGFR E746_A750del
|
NSCLC
|
EGFR E746_A750del
|
NSCLC
|
neratinib Sensitive: D – Preclinical
|
neratinib Sensitive: D – Preclinical
|
EGFR E746_A750del
|
NSCLC
|
EGFR E746_A750del
|
NSCLC
|
MCLA-129 Sensitive: D – Preclinical
|
MCLA-129 Sensitive: D – Preclinical
|